FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 09/29/2021 |
3. Issuer Name and Ticker or Trading Symbol
Procaps Group, S.A. [ PROC ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Ordinary Shares | 15,877,516 | I | Shares indirectly held through Hoche Partners Pharma Holding S.A. |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
Explanation of Responses: |
/s/ Alexandre "Alejandro" Weinstein Manieu | 10/12/2021 | |
/s/ Roman Sokolowski, Director, Hoche Partners Pharma Holding S.A. | 10/12/2021 | |
/s/ Peter Egan and /s/ Ariane Vansimpsen, Directors, Stonehage Fleming Corporate Service Luxembourg S.A., Director | 10/12/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 24
Information Regarding Joint Filers
Designated Filer of Form 4: Alexandre “Alejandro” Weinstein Manieu
Date of Earliest Transaction Required to be Reported: September 29, 2021
Issuer Name and Ticker Symbol: Procaps Group, S.A. (PROC)
Names: | Alexandre “Alejandro” Weinstein Manieu and Hoche Partners Pharma Holding S.A. |
Address: | Alexandre “Alejandro” Weinstein Manieu Calle 80 No. 78B-201 Barranquilla, Colombia 80004 Hoche Partners Pharma Holding S.A. 3A Val Sainte Croix Luxembourg, Luxembourg L-1371 |
Signatures:
The undersigned, Alexandre “Alejandro” Weinstein Manieu and Hoche Partners Pharma Holding S.A are jointly filing the attached Statement of Changes in Beneficial Ownership of Securities on Form 3 with respect to the beneficial ownership of securities of Procaps Group, S.A.
ALEXANDRE “ALEJANDRO” WEINSTEIN MANIEU
/s/ Alexandre “Alejandro” Weinstein Manieu
Signature
Alexandre “Alejandro” Weinstein Manieu/Director
Name/Title
HOCHE PARTNERS PHARMA HOLDING S.A.
/s/ Roman Sokolowski
Signature
Roman Sokolowski/Director
Name/Title
STONEHAGE FLEMING CORPORATE SERVICE LUXEMBOURG S.A., DIRECTOR
/s/ Peter Egan
Signature
Peter Egan/Director
Name/Title
/s/ Ariane Vansimpsen
Signature
Ariane Vansimpsen/Director
Name/Title